Integer Holdings Corp adjusts medical portfolio, shares track sector peers
29.06.2026 - 19:35:26 | ad-hoc-news.de
By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-29, 19:34.
Integer Holdings Corp (US45826J1051) continues to operate as a key contract manufacturer for medical device and cardiovascular companies, with its shares listed on the NYSE next to sector peers such as Medtronic and Boston Scientific. The company maintains a diversified portfolio across cardiac rhythm management, neuromodulation and vascular products, according to recent investor materials and third-party coverage.
How Integer positions itself
Integer Holdings Corp presents itself as a leading medical device outsource manufacturer, supplying proprietary components and finished devices to major healthcare OEMs across the United States, Europe and Asia. Its investor relations site describes core capabilities in design, development and manufacturing for cardiac, neuromodulation and vascular therapies. Integer investor presentation
The company emphasizes long-term contracts and deep engineering partnerships with leading device makers, focusing on complex components such as implantable leads, stimulation electrodes and vascular delivery systems. Industry commentary notes that outsourcing in medical technology has grown steadily as OEMs seek cost efficiency and specialized manufacturing expertise. Reuters analysis on medtech outsourcing
Weekday focus on operations
Operations at Integer span multiple manufacturing sites in North America, Europe and Asia, with facilities dedicated to precision machining, molding, assembly and sterilization of medical products. The company reports ongoing investments in automation and quality systems to meet stringent regulatory requirements from bodies such as the FDA and European authorities. Integer annual report
Integer’s strategy centers on deepening relationships with large OEM clients while expanding into adjacent categories like neuromodulation and structural heart, according to analyst commentary tracking the medtech contract manufacturing space. Coverage from sell-side research highlights solid demand for minimally invasive devices and implantable technologies, which supports long-term volume for component suppliers. Morgan Stanley medtech outsourcing note
Further news and analysis on Integer Holdings Corp shares
More updates, filings and price data on Integer Holdings Corp are available in the dedicated topic section and on the company's investor relations pages.
The product behind the stock
One representative product line for Integer Holdings Corp is its implantable cardiac leads, which are used in devices such as pacemakers and cardioverter defibrillators produced by major OEMs. These leads must maintain long-term reliability inside the body, requiring advanced materials, insulation systems and precision manufacturing.
Where the stock trades today
Integer Holdings Corp shares trade on the NYSE in US dollars; a current, verified price was not available at the time of writing, but the listing remains active on the exchange.
Integer Holdings Corp at a glance
- Company: Integer Holdings Corp
- ISIN: US45826J1051
- WKN: A2AJ90
- Ticker: ITGR
- Trading venue: NYSE
- Price (as of 2026-06-29, 19:34): not verifiable USD
- Market cap: not verifiable USD (as of 2026-06-29)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: not in a major headline index
- Next earnings date: not officially scheduled
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
